ZNF148 and colorectal carcinoma: However, one study found that reduced expression of ZNF148 in CRC is strongly associated with several adverse clinical features, including lymph node metastasis, advanced TNM stage, poor differentiation, high recurrence rates, short overall survival, and disease‐free survival [21].